PROTECTIVE EFFECTS OF A NEUROTROPHIC ACTH((4-9)) ANALOG ON CISPLATIN OTOTOXICITY IN RELATION TO THE CISPLATIN DOSE - AN ELECTROCOCHLEOGRAPHIC STUDY IN ALBINO GUINEA-PIGS
Chm. Stengs et al., PROTECTIVE EFFECTS OF A NEUROTROPHIC ACTH((4-9)) ANALOG ON CISPLATIN OTOTOXICITY IN RELATION TO THE CISPLATIN DOSE - AN ELECTROCOCHLEOGRAPHIC STUDY IN ALBINO GUINEA-PIGS, Hearing research, 124(1-2), 1998, pp. 108-117
Cisplatin is a potent cell cycle non-specific chemotherapeutic agent t
hat produces side effects including high-frequency hearing loss. Hamer
s et al. (1994) studied electrophysiologically the effect of an ACTH((
4-9)) analog, also known as ORG2766, on the ototoxicity of cisplatin (
administered at 2 mg/kg/day for 8 days) in guinea pigs. ORG2766 was gi
ven concomitantly with cisplatin during the 8 day period and an additi
onal dose was given on day 9. The conclusion of this study was that OR
G2766 might partially prevent cisplatin ototoxicity, but that the chos
en cisplatin dose (2 mg/kg/day; 8 days) might have been too high. Beca
use of the high cisplatin dose the protective power of the co-treatmen
t with ORG2766 might not have stretched to all animals. In this study
the results of co-treatment with the same dose and daily schedule of O
RG2766 and cisplatin doses of 1.0 mg/kg/day and 1.5 mg/kg/day for 8 da
ys are presented. The measurements were performed over a broad range o
f frequencies (0.5-16 kHz). Electrocochleography was performed at day
10. In the 1.0 mg/kg/day group there was no beneficial effect of ORG27
66, although a tendency towards a division between a subgroup resembli
ng control animals and a subgroup with severe cisplatin effects was no
ted in the co-treated group. In the 1.5 mg/kg/day co-treated group thr
ee animals showed compound action potential (CAP) amplitudes close to
those of the controls at all frequencies except the very highest (12 a
nd 16 kHz), the remaining three had CAP amplitudes comparable to those
of animals in the cisplatin alone group. The effect of ORG2766 on the
latter group of six animals taken together was statistically signific
ant. The dichotomy in the results for the 1.5 mg/kg/day group co-treat
ed with ORG2766 suggests that ORG2766 may have a protective effect aga
inst cisplatin ototoxicity which, however, depends on a factor current
ly unknown. (C) 1998 Elsevier Science B.V. All rights reserved.